(Q36589292)

15 August 2017

1 reference

title

A new, broad-spectrum azole antifungal: posaconazole--mechanisms of action and resistance, spectrum of activity (English)

1 reference

15 August 2017

H Hof

1

1 reference

PubMed ID

16961575

15 August 2017

language of work or name

1 reference

1 January 2006

1 reference

15 August 2017

1 reference

15 August 2017

49 Suppl 1

1 reference

15 August 2017

2-6

1 reference

An update on antifungal targets and mechanisms of resistance in Candida albicans

15 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01295.X

Posaconazole is a potent inhibitor of sterol 14alpha-demethylation in yeasts and molds

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01295.X

Three-dimensional models of wild-type and mutated forms of cytochrome P450 14alpha-sterol demethylases from Aspergillus fumigatus and Candida albicans provide insights into posaconazole binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01295.X

Contribution of mutations in the cytochrome P450 14alpha-demethylase (Erg11p, Cyp51p) to azole resistance in Candida albicans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01295.X

Changes in susceptibility to posaconazole in clinical isolates of Candida albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01295.X

Application of real-time quantitative PCR to molecular analysis of Candida albicans strains exhibiting reduced susceptibility to azoles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01295.X

Phenotypic and genotypic evaluation of fluconazole resistance in vaginal Candida strains isolated from HIV-infected women from Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01295.X

A comparative study of the in vitro susceptibilities of clinical and laboratory-selected resistant isolates of Aspergillus spp. to amphotericin B, itraconazole, voriconazole and posaconazole (SCH 56592).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01295.X

Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01295.X

Antifungal susceptibility of 596 Aspergillus fumigatus strains isolated from outdoor air, hospital air, and clinical samples: analysis by site of isolation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01295.X

In vitro activities of posaconazole, itraconazole, voriconazole, amphotericin B, and fluconazole against 37 clinical isolates of zygomycetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01295.X

Effect of media composition and in vitro activity of posaconazole, caspofungin and voriconazole against zygomycetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01295.X

Zygomycetes in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01295.X

Recognition of extracellular matrix proteins by Paracoccidioides brasiliensis yeast cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01295.X

Molecular aspects of fluconazole resistance development in Candida albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01295.X

Critical annotations to the use of azole antifungals for plant protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01295.X

Posaconazole: clinical pharmacology and potential for management of fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01295.X

Quality control and reference guidelines for CLSI broth microdilution susceptibility method (M 38-A document) for amphotericin B, itraconazole, posaconazole, and voriconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01295.X

10.1111/J.1439-0507.2006.01295.X

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference

PubMed ID

16961575